Rounds
Dense with clinical breakthroughs, policy shifts, and the quiet signals that reshape medicine — before the mainstream press catches wind.
Every Friday morning. No noise, just signal.
Recent Editions
Buried in 847 pages of proposed rulemaking is a reimbursement shift that will quietly reroute $2.3 billion in cardiac procedure revenue by Q3. We read every page so you don't have to.
The 36-month follow-up data arrived quietly in a supplemental appendix. The signal is clear enough that three NCI-designated centers have already revised their first-line recommendations.
If you're building or evaluating AI diagnostics tools, the PCCP guidance issued last Tuesday is the most consequential regulatory document since the De Novo pathway. Here's what changed.
"Every issue is edited to the standard of a journal submission — because that is the standard your time deserves."
Every claim traces back to peer-reviewed literature, official regulatory filings, or named clinical authorities.
We read the full study, the dissenting commentary, and the methodology before we form a sentence.
Each edition is built around a single clinical or policy theme — explored with the depth it warrants.
Reader Voices
I forward the best issues to my entire residency cohort. The signal-to-noise ratio is unlike anything else in my inbox — it reads like a colleague who did the reading for me.
As a CMO scanning between cases, I need depth without volume. Rounds delivers the former and eliminates the latter. It's the one newsletter I've never unsubscribed from.
The FDA coverage alone is worth the subscription. When the PCCP guidance dropped, Rounds had the clinical implications mapped before any trade publication touched it.
Dense, accurate, and written with genuine clinical vocabulary. It's one of the few external reads I allow to interrupt my schedule.
Join 12,400 Clinicians
Every Friday morning, Rounds arrives with the one clinical story that changed something this week — sourced, contextualized, and written at the level your training prepared you for.